JFGIW
CYTK icon

Johnson Financial Group Inc (Wisconsin)’s Cytokinetics CYTK Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.98K Hold
35
– – ﹤0.01% 738
2026
Q1 		$2.31K Hold
35
– – ﹤0.01% 772
2025
Q4 		$2.22K Sell
35
-686
-95% -$42.7K ﹤0.01% 802
2025
Q3 		$39.6K Buy
+721
New +$29.7K ﹤0.01% 640

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s CYTK Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) held its Cytokinetics (CYTK) position steady in Q2 2026 at 35 shares worth $2.98K. The position accounts for ﹤0.01% of the portfolio, ranked #738.

Johnson Financial Group Inc (Wisconsin) first reported a position in CYTK in Q3 2025 and has held it in 4 quarters since. The position peaked at $39.6K in Q3 2025. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Johnson Financial Group Inc (Wisconsin) held 35 shares of Cytokinetics worth $2.98K as of Q2 2026.
  • Johnson Financial Group Inc (Wisconsin) left its Cytokinetics share count unchanged in Q2 2026.
  • Cytokinetics made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #738 holding.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Cytokinetics in Q3 2025 and has held it in 4 quarters since.
  • Johnson Financial Group Inc (Wisconsin)'s Cytokinetics position peaked at $39.6K in Q3 2025.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.